Jupiter Neurosciences (JUNS) files notice of late Q2 2025 10-Q

Rhea-AI Filing Summary

Jupiter Neurosciences, Inc. filed a notice that it will be late in submitting its Quarterly Report on Form 10-Q for the period ended June 30, 2025. The company states it could not complete the filing on time without unreasonable effort or expense.

Management explains that it needs additional time to finish preparing and reviewing its financial statements and related disclosures. The company expects to file the Form 10-Q no later than the fifth calendar day after the original due date, consistent with the extension allowed under Rule 12b-25.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING	OMB APPROVAL
	OMB Number: 3235-0058
	Expires: August 31, 2025
	Estimated average burden hours per response ... 2.50
	SEC FILE NUMBER
	001-41265
	CUSIP NUMBER 48208B203

(Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR

		For Period Ended:	June 30, 2025
		☐ Transition Report on Form 10-K
		☐ Transition Report on Form 20-F
		☐ Transition Report on Form 11-K
		☐ Transition Report on Form 10-Q
		☐ Transition Report on Form N-SAR
		For the Transition Period Ended:

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I — REGISTRANT INFORMATION

Jupiter Neurosciences, Inc.

Full Name of Registrant

Former Name if Applicable

1001 North US HWY 1, Suite 504

Address of Principal Executive Office (Street and Number)

Jupiter, FL 33477

City, State and Zip Code

PART II — RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

☒	(a)	The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
	(b)	The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
	(c)	The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III — NARRATIVE

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

JUPITER NEUROSCIENCES, INC. (the “Registrant”) was unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025 (the “Form 10-Q”) within the prescribed time period applicable to smaller reporting companies because it requires additional time to complete the presentation and review of its financial statements and related disclosures. The Registrant anticipates that it will file the Form 10-Q no later than the fifth calendar day following the prescribed filing date.

PART IV — OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification

Christer Rosén		(561)		406-6154
(Name)		(Area Code)		(Telephone Number)

(2)	Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
	Yes ☒ No ☐
(3)	Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
	Yes ☐ No ☒
	If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

JUPITER NEUROSCIENCES, INC.

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

August 14, 2025	By:	/s/ Christer Rosén
	Name:	Christer Rosén
	Title:	Chief Executive Officer

FAQ

Why did Jupiter Neurosciences (JUNS) delay its Form 10-Q filing?

Jupiter Neurosciences delayed its Form 10-Q because it needed more time to complete and review its financial statements and related disclosures. The company stated that filing on time was not possible without unreasonable effort or expense, so it used the permitted short extension.

Which period does the late Form 10-Q for Jupiter Neurosciences (JUNS) cover?

The late Form 10-Q for Jupiter Neurosciences covers the quarterly period ended June 30, 2025. This report will provide detailed financial statements and disclosures for that quarter once filed under the extended timeframe allowed by Rule 12b-25.

When does Jupiter Neurosciences (JUNS) expect to file the delayed 10-Q?

Jupiter Neurosciences expects to file the delayed Form 10-Q no later than the fifth calendar day after its original due date. This timing is consistent with the short extension period available for quarterly reports under Rule 12b-25.

What regulation allows Jupiter Neurosciences (JUNS) extra time to file its 10-Q?

Jupiter Neurosciences is relying on Rule 12b-25, which permits a brief extension for certain SEC reports. By filing this notification, the company indicates it will submit the Form 10-Q within five calendar days after the prescribed due date.

Does Jupiter Neurosciences (JUNS) mention issues with prior SEC reports?

The notification asks whether all other required periodic reports have been filed, but the excerpt does not detail any missing prior reports. The main focus is on the timing of the Form 10-Q for the quarter ended June 30, 2025.

Does Jupiter Neurosciences (JUNS) indicate a significant change in results of operations?

The form includes a question about significant changes in results of operations compared with the prior year’s period. However, the provided excerpt does not include any narrative or quantitative explanation of such changes for Jupiter Neurosciences.